Managing multiple medications in older adults with chronic diseases
Official title: Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
Run by Xijing Hospital · NCT07180368 · Data updated 2026-11-12
This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Xijing Hospital Academic / other |
| Locations | 1 site (Xi'an, Shaanxi) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2027 |
| Registry record updated | September 18, 2025 |
| Trial ID | NCT07180368 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are people aged 65 or older with at least one chronic disease, stable vital signs, and willingness to complete online surveys over two years.
✕Probably not a fit
People without chronic diseases, those with unstable vital signs, or individuals unwilling or unable to participate in online surveys are unlikely to gain benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows patients aged 65 and older with one or more chronic diseases to see how polypharmacy relates to their prognosis over two years. Participants at Xijing Hospital will complete periodic online surveys about their medications, symptoms, and health events. No experimental treatments are given; researchers will analyze survey data to link medication burden with outcomes such as hospitalization, disease progression, or mortality. The goal is to identify medication patterns associated with poorer prognosis and inform safer prescribing for older adults.
Why it matters
Potential benefit: If successful, the findings could help clinicians simplify medication regimens and reduce harm, improving quality of life and health outcomes for older patients.
How similar studies have gone: Previous observational research has repeatedly linked polypharmacy to worse outcomes in older adults, while interventional deprescribing studies have shown mixed but sometimes positive results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 65 years or older with at least one chronic disease Exclusion Criteria: * Patients without chronic diseases * Patients refused to participate in the study * Patients with unstable vital signs
Where it's running
-
Xijing Hospital
Xi'an, Shaanxi, China Recruiting
Study contacts
- Study coordinator: Ming Yuan, MD, PhD
- Email: 1446534236@qq.com
- Phone: 029-84775188
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases
This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.
-
Comparing a standard versus an intensified interactive Get Ready app to support patients having bariatric surgery
This trial tests whether an intensified, interactive version of the Get Ready smartphone app helps people having bariatric surgery follow their pre- and post‑operative plan better than the standard app.
-
Fueling Strong Hearts for South Carolina stroke survivors.
This program will test whether a virtual lifestyle program that adds medically tailored groceries to a peer-led exercise and nutrition class helps adults 45–80 with chronic stroke and overweight or obesity improve activity, diet, and quality of life.
-
UBT251 injection for adults with overweight or obesity and chronic kidney disease
This randomized, double-blind trial will test whether UBT251 injections help obese or overweight adults with chronic kidney disease.
-
Integrated care for older patients with atrial fibrillation
This study is testing a new team-based care approach for older patients with atrial fibrillation and other health issues to see if it helps them manage their condition better than regular care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.